Jaguar Health (JAGX) Prices 4.438M Share Registered Direct Offering at $3.38/Sh

Jaguar Health, Inc. (NASDAQ: JAGX) today announced it has entered into a securities purchase agreement with two institutional investors including a high-net-worth family office for the purchase and sale of 4,437,870 shares of common stock at a purchase price of $3.38 per share for gross proceeds of approximately $15.0 million in a registered direct offering priced above-the-market under Nasdaq rules.

Ladenburg Thalmann & Co. Inc. is acting as exclusive placement agent in connection with the offering.

The closing of the offering is expected to take place on or about January 15, 2021, subject to the satisfaction or waiver of customary closing conditions.

You May Also Be Interested In

• Jaguar Health provides crofelemer to infant for compassionate use
• Agilent launches FDA-cleared S540MD slide scanner in the U.S.
• Honda Motor names Mamadou Diallo as Auto Business Center EVP